3137 results for «992»
3137 results
TAVR in challenging anatomies
17 May 2024 – From EuroPCR 2024
This session focuses on navigating TAVR procedures in complex anatomical scenarios. It covers topics such as optimizing the position of a TAVR valve in a stentless bioprosthesis, managing an unexpected deep position of a TAVR implant, dealing with a completely radiolucent failing surgical bioprosthetic valve, and...
ACS: how to approach special clinical scenarios
17 May 2024 – From EuroPCR 2024
This session focuses on the management of acute coronary syndrome (ACS) in special clinical scenarios. It covers topics such as treating ACS with multivessel disease, managing an ACS and unstable patient, and addressing subacute myocardial infarction. The session features case presentations and discussions, providing insights and...
TAVI: how to prevent stroke
17 May 2024 – From EuroPCR 2024
This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.
Challenging tricuspid TEER cases
22 May 2025 – From EuroPCR 2025
Explore challenging tricuspid transcatheter edge-to-edge repair (TEER) cases highlighting combined LAA occlusion and mitral valve repair, anatomical complexities, and strategies to complete surgical interventions percutaneously. Discuss the balance between procedural perfection and clinical practicality in complex valve anatomies.
Troubleshooting and management communication in LAA closure
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on troubleshooting and communication during left atrial appendage (LAA) closure procedures. Covering device migration management, transeptal puncture in high bleeding risk patients, scoliosis adaptations, and advanced catheter techniques, it emphasizes practical solutions for procedural complications.
Clinical impact of mechanical circulatory support
22 May 2025 – From EuroPCR 2025
Explore the clinical impact of mechanical circulatory support through a series of detailed presentations covering protocols and training effects on outcomes in left-sided micro-axial flow-supported shock patients, practice variations between Sweden and the U.S., six-month outcomes post coronary intervention with VA-ECMO, and the prognostic value of...
Navigating complexity: TAVI in challenging anatomies
22 May 2025 – From EuroPCR 2025
Navigate the complexities of TAVI in challenging anatomies. This session reviews anatomical variations such as horizontal aorta, iliofemoral tortuosity, low coronary ostia, bicuspid valves, and annular eccentricity, alongside preprocedural imaging and risk stratification. It further evaluates device selection and procedural adaptations essential for successful TAVI in...
ACS management: when imaging matters
22 May 2025 – From EuroPCR 2025
This session focuses on the critical role of intracoronary imaging in acute coronary syndrome (ACS) management. Topics include spontaneous coronary artery dissection (SCAD) cases, the utilization of IVUS and cardiac CT in emergent PCI during cardiogenic shock, and the assessment of non-culprit lesions using OCT to...
Antiplatelet strategies for clinical dilemmas
22 May 2025 – From EuroPCR 2025
Dive into the complexities of antiplatelet strategies tailored for challenging clinical scenarios. This session covers antiplatelet therapy in myocardial bridge, bleeding risk reduction via ticagrelor removal before urgent CABG, peri-procedural management for patients on oral anticoagulants undergoing PCI, and the use of cangrelor in out-of-hospital cardiac...
TAVI coronary access
22 May 2025 – From EuroPCR 2025
Gain expertise in managing coronary access challenges in TAVI patients. This session discusses when and how to treat coronary lesions in TAVI candidates, strategies to facilitate coronary approach post-TAVI, and long-term outcomes with practical tips through illustrative cases including primary PCI after CoreValve implantation and valve-in-valve...
When angina cannot be cured with stents: what are the remaining options
22 May 2025 – From EuroPCR 2025
Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.
TAVI - Outcomes predictors
22 May 2025 – From EuroPCR 2025
Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.
Retrograde removal of the broken sheath
22 May 2025 – From EuroPCR 2025
This session addresses complex complications during vascular access with a focus on retrograde removal of broken sheaths. Learn to recognize critical signs, manage rare but severe complications including broken guidewires in the radial artery, and explore innovative off-label solutions for challenging scenarios.
Novel tools and techniques to manage complex PCI scenarios
22 May 2025 – From EuroPCR 2025
This session introduces novel tools and techniques to manage complex PCI scenarios. Key topics include intravascular lithotripsy advancements for in-stent restenosis, innovative balloon-assisted fenestration of covered stents, long-term outcomes of drug-eluting balloons post directional coronary atherectomy, and safety and efficacy data on a novel high-pressure cutting...
TAVI for aortic regurgitation off label
22 May 2025 – From EuroPCR 2025
Explore off-label applications of TAVI for aortic regurgitation in complex clinical scenarios. Topics include TAV-in-SAV with Trilogy valve for severe regurgitation, challenges of transcatheter prosthesis in pure aortic regurgitation, management of surgical valve perforations, and treatment strategies in post-surgical anatomies including degenerative homografts and aortic dissection.
Coronary protection during native and valve-in-valve TAVI
22 May 2025 – From EuroPCR 2025
Understand the critical role of coronary protection during native and valve-in-valve transcatheter aortic valve implantation (TAVI). This session covers procedural planning essentials, the impact of upfront coronary protection, challenges in coronary obstruction diagnosis, and the use of guide catheter extension to facilitate protection during TAVI procedures.
Acute complications during distal left main PCI - Part 3
22 May 2025 – From EuroPCR 2025
This session highlights acute complications during distal left main PCI. It presents cautionary cases of incorrect left main stenting, catastrophic left main V stenting outcomes, unprotected left main thrombosis, and survival strategies when new technologies fail unexpectedly.
Management of bifurcations with complex anatomy - Part 1
22 May 2025 – From EuroPCR 2025
This session addresses the management of bifurcations with complex anatomy through a series of challenging case studies. It features a traumatic coronary artery dissection, anomalous right coronary artery PCI, CTO interventions complicated by proximal dissection, double CTO PCI for complete revascularization, and a challenging calcified left...
Peripheral interventions: the hidden key for complications
22 May 2025 – From EuroPCR 2025
Uncover the critical role of peripheral interventions in managing complications. This session shares case stories of lost stents, unusual TAVI access complications, percutaneous removal of misplaced devices, revascularisation of iatrogenic pseudoaneurysms, and challenges when multiple closure devices are insufficient.
